{"DataElement":{"publicId":"7166341","version":"1","preferredName":"PK Sampling Planned Time Point Name","preferredDefinition":"The protocol description of planned time point when measurements should be taken as defined by the sponsor.","longName":"PC_PCTPT_SPD","context":"NRDS","contextVersion":"1","DataElementConcept":{"publicId":"6411498","version":"1","preferredName":"Pharmacokinetic Concentration Domain Pharmacokinetic Concentration Timepoint","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to pharmacokinetic concentration._A point in time referring to pharmacokinetic concentration data.","longName":"6408442v1.0:6411496v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6408442","version":"1","preferredName":"Pharmacokinetic Concentration Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to pharmacokinetic concentration.","longName":"C49606","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacokinetic Concentration Domain","conceptCode":"C49606","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to pharmacokinetic concentration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73FAB69B-50DC-5473-E053-F662850A5E5B","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6411496","version":"1","preferredName":"Pharmacokinetic Concentration Timepoint","preferredDefinition":"A point in time referring to pharmacokinetic concentration data.","longName":"C87974","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacokinetic Concentration Timepoint","conceptCode":"C87974","definition":"A point in time referring to pharmacokinetic concentration data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74229DA7-7B37-77CA-E053-F662850AEC9E","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"74229DA7-7B48-77CA-E053-F662850AEC9E","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-23","modifiedBy":"KUMMEROA","dateModified":"2021-06-11","changeDescription":"2021-6-11 ak Released per governance approval.; 2/24/20 tmt released. Created as part of the CDISC mapping task_ghd_08.23.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7166340","version":"1","preferredName":"Pharmacokinetic Concentration Timepoint Clinical Study Sponsor Defined Name","preferredDefinition":"A point in time referring to pharmacokinetic concentration data._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.","longName":"PCTPT_SPD","context":"NRDS","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E670F4E-9268-5870-E053-F662850A6343","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-12","modifiedBy":"ONEDATA","dateModified":"2020-02-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7181426","version":"1","preferredName":"Pharmacokinetic Concentration Timepoint Clinical Study Sponsor Defined Name","preferredDefinition":"A point in time referring to pharmacokinetic concentration data.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:The words or language units by which a thing is known.","longName":"C87974:C70793:C165683:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacokinetic Concentration Timepoint","conceptCode":"C87974","definition":"A point in time referring to pharmacokinetic concentration data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F182584-C8EC-7185-E053-F662850AE900","latestVersionIndicator":"Yes","beginDate":"2020-02-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-21","modifiedBy":"ONEDATA","dateModified":"2020-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E670F4E-9252-5870-E053-F662850A6343","latestVersionIndicator":"Yes","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-12","modifiedBy":"TAYLORT","dateModified":"2020-02-24","changeDescription":"2/24/20 tmt released/Theradex reuse. 2/12/20 Created to support sponsor defined codelists; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"7066596","version":"1","longName":"CDISC (NRDS Implementation)","context":"NRDS"},{"publicId":"7067375","version":"1","longName":"Sponsor Defined","context":"NRDS"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"CDASH Prompt","type":"Alternate Question Text","description":"[Planned Time Point Name]","url":null,"context":"NRDS"},{"name":"Case Report Form Completion Instructions","type":"CDISC CRF Instruction","description":"Maps directly to the SDTMIG variable. See SDTMIG for additional information on representing time points. The SDTMIG time point anchors PCTPTREF (text description) and PCRFTDTC (date/time) may be needed, as well as SDTMIG variables PCTPTNUM, PCELTM.","url":null,"context":"NRDS"},{"name":"CDASH Implementation Notes","type":"CDASH Implementation Note","description":"Planned time point are needed to differentiate multiple sequential assessments. It is recommended that time points should be pre-printed on the CRF rather than collected in a field that requires the site to enter text. If the form is laid out as a grid, then words such as Planned Time Point can be included as the column header.","url":null,"context":"NRDS"},{"name":"What was the planned time poi","type":"Preferred Question Text","description":"What was the planned time point of the PK sample collection?","url":null,"context":"NRDS"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Planned Time Point","url":null,"context":"Theradex"},{"name":"Permissible","type":"SDTM Core","description":"Permissible","url":null,"context":"NRDS"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E67153E-BB20-5ACE-E053-F662850AEB16","latestVersionIndicator":"Yes","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-12","modifiedBy":"TAYLORT","dateModified":"2020-02-24","changeDescription":"2/24/20 tmt released/Theradex reuse. 2/12/20 Created to support sponsor defined codelists; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}